Skip to main content
Retour
Watch Compare

cbdMD, Inc.

Qualité des données : 100%
YCBD
NYSE Manufacturing Chemicals
0,68 €
▲ 0,03 € (3,99%)
Cap. Boursière: 7,03 M
Prix
0,67 €
Cap. Boursière
7,03 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -18,95% annually over 5 years
Negative free cash flow of -1,64 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 17,45%
Capital efficient — spends only 0,96% of revenue on capex

Croissance

Revenue Growth (5Y)
-18,95%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-1,50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-60,24%
En dessous de la moyenne du secteur (-53,53%)
ROIC-46,31%
Net Margin-10,63%
Op. Margin-11,27%

Sécurité

Debt / Equity
N/A
Current Ratio1,56
Interest Coverage-63,03

Valorisation

PE (TTM)
-3,45
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,15
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -3,5 -1,5
P/B 1,2 1,6
ROE % -60,2 -53,5
Net Margin % -10,6 -41,5
Rev Growth 5Y % -19,0 1,8
D/E — 0,3

Objectif de Cours des Analystes

1 analyste
Strong Buy
Actuel
0,68 €
+194.1%
Objectif
2,00 €
2,00 €
2,00 €
2,00 €
Prévisions
BPA Prévisionnel -0,07 €
CA Est. 22,69 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,07 €
-0,07 € – -0,07 €
 22,69 M 1
FY2026 -0,14 €
-0,14 € – -0,14 €
 21,20 M 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,06 € -0,04 € +33,3%
Q32025 -0,07 € N/A —
Q22025 -0,16 € -0,21 € -31,3%
Q12025 -1,60 € -1,90 € -18,8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -1,50% Revenue Growth (3Y) -10,87%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -18,95% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 19,19 M Net Income (TTM) -2,04 M
ROE -60,24% ROA -19,59%
Gross Margin 62,37% Operating Margin -11,27%
Net Margin -10,63% Free Cash Flow (TTM) -1,64 M
ROIC -46,31% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,56
Interest Coverage -63,03 Asset Turnover 1,84
Working Capital 2,01 M Tangible Book Value 3,79 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,45 Forward P/E N/A
P/B Ratio 1,15 P/S Ratio 0,37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23,27%
Market Cap 7,03 M Enterprise Value 5,97 M
Per Share
EPS (Diluted TTM) -1,09 Revenue / Share 1,83
FCF / Share -0,16 OCF / Share -0,14
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,96% FCF Conversion 80,19%
SBC-Adj. FCF N/A Growth Momentum 17,45

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 19,19 M 19,48 M 24,16 M 35,40 M 44,48 M
Net Income -2,04 M -3,70 M -22,94 M -70,08 M -23,39 M
EPS (Diluted) -1,09 -1,79 -13,32 -1,24 -0,47
Gross Profit 11,97 M 12,00 M 14,98 M 22,34 M 29,99 M
Operating Income -2,16 M -3,32 M -22,49 M -78,27 M -19,62 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — 1,02 M
Interest Expense 34 308,0 -29 507,0 63 702,0 16 246,0 -28 930,0
Income Tax 0,0 0,0 0,0 0,0 895 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10,42 M 10,58 M 16,20 M 40,79 M 124,88 M
Total Liabilities 3,19 M 8,62 M 7,16 M 9,37 M 21,74 M
Shareholders' Equity 7,23 M 1,96 M 9,03 M 31,42 M 103,14 M
Total Debt — — 9,0 125 491,0 108 985,0
Cash & Equivalents 2,26 M 2,45 M 1,80 M 6,72 M 26,41 M
Current Assets 6,55 M 6,39 M 8,07 M 16,01 M 36,50 M
Current Liabilities 3,19 M 8,62 M 4,67 M 5,29 M 6,92 M